Selective estrogen receptor modulators and deep venous thrombosis after an emergent operation in senior women

BACKGROUND: Selective estrogen receptor modulators (SERMs), clinically applied to osteoporosis, may have potential risk of deep venous thrombosis (DVT) and discontinuation of SERMs may be required before surgery. However, we cannot discontinue SERMs for a certain duration, when patients undergo an e...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishida, Keiko, Furukawa, Masanobu, Nakashima, Masayuki, Kubota, Idumi, Hayashi, Yukio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624775/
https://www.ncbi.nlm.nih.gov/pubmed/37921988
http://dx.doi.org/10.1186/s40981-023-00665-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624775/
https://www.ncbi.nlm.nih.gov/pubmed/37921988
http://dx.doi.org/10.1186/s40981-023-00665-1

Ejemplares similares